Treatments for Juvenile idiopathic arthritis
FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.
FDA-approved treatments (12)
- KineretanakinraSwedish Orphan Biovitrum AB (publ)
- PenicillaminePENICILLAMINEEndo USA, Inc.
- PIROXICAMPIROXICAMUnichem Pharmaceuticals (USA), Inc.
- MethotrexateMethotrexate sodiumLederle Laboratories
- SIMPONI ARIA�golimumabJanssen Research & Development, LLC
- RemicadeinfliximabJanssen Biotech, Inc.
- OrenciaabataceptBristol-Myers Squibb Co.
- RinvoqupadacitinibAbbVie, Inc.
- HUMIRAadalimumabAbbVie, Inc.
- ActemratocilizumabGenentech, Inc.
- MobicmeloxicamAvondale PharmaceuticalsApproved Aug 2005
- EnbreletanerceptImmunex CorporationApproved May 1999
Patient support programs (11)
Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.
DEXAMETHASONE SODIUM PHOSPHATE
Merck
Rheumatoid Arthritis
Mobic
Avondale Pharmaceuticals
ORENCIA
Bristol Myers Squibb
Rheumatoid Arthritis
Rinvoq
AbbVie
Rheumatoid Arthritis
ENBREL
Amgen
Rheumatoid Arthritis
Kineret
Sobi
Rheumatoid Arthritis
SIMPONI ARIA
Janssen
Rheumatoid Arthritis
METHOTREXATE
Unknown
Rheumatoid Arthritis
Adalimumab
AbbVie
Rheumatoid Arthritis
Simponi
Janssen
Rheumatoid Arthritis
Humira
AbbVie
Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Crohn's Disease, Ulcerative Colitis, Plaque Psoriasis, Hidradenitis Suppurativa, Uveitis